BDCDA seeks reconsideration of Karnataka Drugs & Cosmetics Rules Amendments: Nandita Vijayasimha, Bengaluru Saturday, January ...
Jersey City, New Jersey Saturday, January 10, 2026, 09:00 Hrs [IST] ...
Diabeloop receives US FDA 510(k) clearance for DBLG2, an automated insulin delivery algorithm: Grenoble, France Saturday, January 10, 2026, 10:00 Hrs [IST] Diabeloop, a global com ...
Gireesh Babu, New Delhi Saturday, January 10, 2026, 08:00 Hrs [IST] ...
Pronto Consult observes India’s 2025 healthcare shift from reactive protection to aspirational prevention: Peethaambaran Kunnathoor, Chennai Saturday, January 10, 2026, 08:00 Hr ...
Panel asks Ayush Ministry to intensify efforts to clear pending Utilisation Certificates: Gireesh Babu, New Delhi Saturday, January 10, 2026, 08:00 Hrs [IST] Raising concerns over ...
Opinion
Experts recommend eliminating inverted duty structure, incentives for research in Union Budget 2026
Experts recommend eliminating inverted duty structure, incentives for research in Union Budget 2026: Shardul Nautiyal, Mumbai Saturday, January 10, 2026, 08:00 Hrs [IST] Experts h ...
SOPHiA GENETICS and MD Anderson announce strategic collaboration to accelerate AI driven precision oncology: Boston, Massachusetts Friday, January 9, 2026, 17:00 Hrs [IST] SOPHiA ...
Allschwil, Switzerland Friday, January 9, 2026, 13:00 Hrs [IST] ...
Merck begins phase 3 KANDLELIT-007 trial of calderasib in combo Keytruda QLEX in certain patients with advanced NSCLC: Rahway, New Jersey Friday, January 9, 2026, 15:00 Hrs [IST] ...
Shilpa Medicare targets US approval of 5-HT3 receptor antiemetic for chemotherapy-induced nausea and vomiting: Our Bureau, Bengaluru Friday, January 9, 2026, 12:15 Hrs [IST] Shilp ...
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has on 7th January, 2026 approved the medicine Nirogacestat hydrobromide (Ogsiveo) for the treatment of progressing desmoid tumours in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback